PDB Short entry for 1EEY HEADER IMMUNE SYSTEM 04-FEB-00 1EEY TITLE CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 TITLE 2 WITH THE SUBSTITUTION (I2L/V5L/L9V) COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA-A2.1 MHC CLASS I (HEAVY CHAIN); COMPND 3 CHAIN: A, D; COMPND 4 FRAGMENT: RESIDUES 1-275 OF EXTRACELLULAR PORTION; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: BETA-2-MICROGLOBULIN (LIGHT CHAIN); COMPND 8 CHAIN: B, E; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: GP2 PEPTIDE; COMPND 12 CHAIN: C, F; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 13 MOL_ID: 3; SOURCE 14 SYNTHETIC: YES; SOURCE 15 OTHER_DETAILS: THE PEPTIDE WAS SYNTHESIZED AT THE PEPTIDE SYNTHESIS SOURCE 16 FACILITY OF UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL. KEYWDS MAJOR HISTICOMPATIBILITY COMPLEX, PEPTIDE BINDING, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR A.K.SHARMA,J.J.KUHNS,E.J.COLLINS REVDAT 4 21-DEC-22 1EEY 1 SEQADV REVDAT 3 24-FEB-09 1EEY 1 VERSN REVDAT 2 29-MAR-05 1EEY 1 JRNL REVDAT 1 10-JUN-03 1EEY 0 JRNL AUTH A.K.SHARMA,J.J.KUHNS,S.YAN,R.H.FRIEDLINE,B.LONG,R.TISCH, JRNL AUTH 2 E.J.COLLINS JRNL TITL CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX ANCHOR JRNL TITL 2 SUBSTITUTIONS ALTER THE CONFORMATION OF T CELL RECEPTOR JRNL TITL 3 CONTACTS. JRNL REF J.BIOL.CHEM. V. 276 21443 2001 JRNL REFN ISSN 0021-9258 JRNL PMID 11287414 JRNL DOI 10.1074/JBC.M010791200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.J.KUHNS,M.A.BATALIA,S.YAN,E.J.COLLINS REMARK 1 TITL POOR BINDING OF HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE REMARK 1 TITL 2 TO A LACK OF INTERACTIONS WITH THE CENTER OF THE PEPTIDE REMARK 1 REF J.BIOL.CHEM. V. 274 36422 1999 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.274.51.36422 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.5 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1060563.400 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.4 REMARK 3 NUMBER OF REFLECTIONS : 38096 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.248 REMARK 3 FREE R VALUE : 0.286 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1907 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.39 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 77.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5027 REMARK 3 BIN R VALUE (WORKING SET) : 0.2880 REMARK 3 BIN FREE R VALUE : 0.3300 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 254 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6292 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 143 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.99000 REMARK 3 B22 (A**2) : -3.63000 REMARK 3 B33 (A**2) : -3.36000 REMARK 3 B12 (A**2) : 1.38000 REMARK 3 B13 (A**2) : 1.11000 REMARK 3 B23 (A**2) : 0.09000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.32 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.780 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 28.69 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: MAXIMUM LIKELIHOOD FUNCTION REMARK 4 REMARK 4 1EEY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-FEB-00. REMARK 100 THE DEPOSITION ID IS D_1000010510. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAY-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38096 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.0700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.18000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% PEG 8000, 25 MM MES, PH6.5., VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: HLA A2 HEAVY CHAIN NONCOVALENTLY ASSOCIATED TO A BETA-2- REMARK 300 MICROGLOBULIN SUBUNIT (LIGHT CHAIN). HEAVY CHAIN IS MADE OF THREE REMARK 300 SUBUNITS ALPHA1, ALPHA 2 AND ALPHA 3. PEPTIDE BINDS TO THE GROOVE REMARK 300 FORMED BY THE ALPHA1 AND ALPHA2 DOMAINS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 HLA A2 HEAVY CHAIN NONCOVALENTLY ASSOCIATED TO A REMARK 400 BETA-2-MICROGLOBULIN SUBUNIT (LIGHT CHAIN). HEAVY CHAIN IS REMARK 400 MADE OF THREE SUBUNITS ALPHA1, ALPHA 2 AND ALPHA 3. PEPTIDE REMARK 400 BINDS TO THE GROOVE FORMED BY THE ALPHA1 AND ALPHA2 DOMAINS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -122.77 57.28 REMARK 500 TRP A 107 15.43 59.52 REMARK 500 HIS A 114 96.07 -163.55 REMARK 500 ASP A 137 -157.75 -137.95 REMARK 500 THR A 178 -70.82 -88.85 REMARK 500 LYS A 243 146.27 -176.14 REMARK 500 HIS B 31 134.19 -174.11 REMARK 500 PRO B 32 -178.62 -65.81 REMARK 500 TRP B 60 -6.37 73.43 REMARK 500 ASP D 29 -124.17 56.06 REMARK 500 TRP D 107 16.44 59.16 REMARK 500 HIS D 114 96.68 -161.66 REMARK 500 TYR D 123 -60.90 -120.31 REMARK 500 ASP D 137 -157.90 -137.08 REMARK 500 THR D 178 -71.51 -88.49 REMARK 500 HIS D 197 12.72 -152.19 REMARK 500 GLN D 224 52.44 -103.81 REMARK 500 HIS E 31 133.81 -175.36 REMARK 500 PRO E 32 -179.19 -65.54 REMARK 500 TRP E 60 -5.16 72.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH D 309 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QR1 RELATED DB: PDB REMARK 900 1QR1 CONTAINS HLA-A2.1 COMPLEXED TO GP2 PEPTIDE REMARK 900 RELATED ID: 1EEZ RELATED DB: PDB REMARK 900 1EEZ CONTAINS HLA-A2.1 COMPLEXED TO GP2 PEPTIDE (I2L/V5L VARIANT) DBREF 1EEY A 1 275 UNP P01892 1A02_HUMAN 1 275 DBREF 1EEY D 1 275 UNP P01892 1A02_HUMAN 1 275 DBREF 1EEY B 0 99 UNP P01884 B2MG_HUMAN 20 119 DBREF 1EEY E 0 99 UNP P01884 B2MG_HUMAN 20 119 DBREF 1EEY C 1 9 PDB 1EEY 1EEY 1 9 DBREF 1EEY F 1 9 PDB 1EEY 1EEY 1 9 SEQADV 1EEY MET B 0 UNP P01884 ALA 20 INITIATING METHIONINE SEQADV 1EEY MET E 0 UNP P01884 ALA 20 INITIATING METHIONINE SEQRES 1 A 275 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 A 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 A 275 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 A 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 275 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 275 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 A 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 A 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 A 275 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 A 275 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 A 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 275 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 A 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 A 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 275 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 275 TRP GLU SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 ILE LEU SER ALA LEU VAL GLY ILE VAL SEQRES 1 D 275 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 D 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 D 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 D 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 D 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 D 275 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 D 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 D 275 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 D 275 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 D 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 D 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 D 275 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 D 275 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 D 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 D 275 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 D 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 D 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 D 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 D 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 D 275 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 D 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 D 275 TRP GLU SEQRES 1 E 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 E 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 E 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 E 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 E 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 E 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 E 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 E 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 F 9 ILE LEU SER ALA LEU VAL GLY ILE VAL FORMUL 7 HOH *143(H2 O) HELIX 1 1 ALA A 49 GLU A 53 5 5 HELIX 2 2 GLY A 56 TYR A 85 1 30 HELIX 3 3 ASP A 137 ALA A 150 1 14 HELIX 4 4 HIS A 151 GLY A 162 1 12 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 GLN A 180 1 6 HELIX 7 7 THR A 225 THR A 228 5 4 HELIX 8 8 GLN A 253 GLN A 255 5 3 HELIX 9 9 ALA D 49 GLU D 53 5 5 HELIX 10 10 GLY D 56 TYR D 85 1 30 HELIX 11 11 ASP D 137 ALA D 150 1 14 HELIX 12 12 HIS D 151 GLY D 162 1 12 HELIX 13 13 GLY D 162 GLY D 175 1 14 HELIX 14 14 GLY D 175 GLN D 180 1 6 HELIX 15 15 THR D 225 THR D 228 5 4 HELIX 16 16 GLN D 253 GLN D 255 5 3 SHEET 1 A 8 GLU A 46 PRO A 47 0 SHEET 2 A 8 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46 SHEET 3 A 8 ARG A 21 VAL A 28 -1 N ALA A 24 O PHE A 36 SHEET 4 A 8 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27 SHEET 5 A 8 THR A 94 VAL A 103 -1 O VAL A 95 N SER A 11 SHEET 6 A 8 PHE A 109 TYR A 118 -1 N LEU A 110 O ASP A 102 SHEET 7 A 8 LYS A 121 LEU A 126 -1 O LYS A 121 N TYR A 118 SHEET 8 A 8 TRP A 133 ALA A 135 -1 N THR A 134 O ALA A 125 SHEET 1 B 4 LYS A 186 ALA A 193 0 SHEET 2 B 4 GLU A 198 PHE A 208 -1 N THR A 200 O HIS A 192 SHEET 3 B 4 PHE A 241 PRO A 250 -1 N PHE A 241 O PHE A 208 SHEET 4 B 4 GLU A 229 LEU A 230 -1 N GLU A 229 O ALA A 246 SHEET 1 C 4 LYS A 186 ALA A 193 0 SHEET 2 C 4 GLU A 198 PHE A 208 -1 N THR A 200 O HIS A 192 SHEET 3 C 4 PHE A 241 PRO A 250 -1 N PHE A 241 O PHE A 208 SHEET 4 C 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 D 4 GLU A 222 ASP A 223 0 SHEET 2 D 4 THR A 214 ARG A 219 -1 N ARG A 219 O GLU A 222 SHEET 3 D 4 TYR A 257 GLN A 262 -1 O THR A 258 N GLN A 218 SHEET 4 D 4 LEU A 270 LEU A 272 -1 O LEU A 270 N VAL A 261 SHEET 1 E 4 LYS B 6 SER B 11 0 SHEET 2 E 4 ASN B 21 PHE B 30 -1 N ASN B 24 O TYR B 10 SHEET 3 E 4 PHE B 62 PHE B 70 -1 N PHE B 62 O PHE B 30 SHEET 4 E 4 GLU B 50 HIS B 51 -1 O GLU B 50 N TYR B 67 SHEET 1 F 4 LYS B 6 SER B 11 0 SHEET 2 F 4 ASN B 21 PHE B 30 -1 N ASN B 24 O TYR B 10 SHEET 3 F 4 PHE B 62 PHE B 70 -1 N PHE B 62 O PHE B 30 SHEET 4 F 4 SER B 55 PHE B 56 -1 O SER B 55 N TYR B 63 SHEET 1 G 4 GLU B 44 ARG B 45 0 SHEET 2 G 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 G 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 G 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 H 8 GLU D 46 PRO D 47 0 SHEET 2 H 8 THR D 31 ASP D 37 -1 O ARG D 35 N GLU D 46 SHEET 3 H 8 ARG D 21 VAL D 28 -1 N ALA D 24 O PHE D 36 SHEET 4 H 8 HIS D 3 VAL D 12 -1 O ARG D 6 N TYR D 27 SHEET 5 H 8 THR D 94 VAL D 103 -1 O VAL D 95 N SER D 11 SHEET 6 H 8 PHE D 109 TYR D 118 -1 N LEU D 110 O ASP D 102 SHEET 7 H 8 LYS D 121 LEU D 126 -1 O LYS D 121 N TYR D 118 SHEET 8 H 8 TRP D 133 ALA D 135 -1 N THR D 134 O ALA D 125 SHEET 1 I 4 LYS D 186 SER D 195 0 SHEET 2 I 4 GLU D 198 PHE D 208 -1 O GLU D 198 N SER D 195 SHEET 3 I 4 PHE D 241 PRO D 250 -1 N PHE D 241 O PHE D 208 SHEET 4 I 4 GLU D 229 LEU D 230 -1 N GLU D 229 O ALA D 246 SHEET 1 J 4 LYS D 186 SER D 195 0 SHEET 2 J 4 GLU D 198 PHE D 208 -1 O GLU D 198 N SER D 195 SHEET 3 J 4 PHE D 241 PRO D 250 -1 N PHE D 241 O PHE D 208 SHEET 4 J 4 ARG D 234 PRO D 235 -1 N ARG D 234 O GLN D 242 SHEET 1 K 4 GLU D 222 ASP D 223 0 SHEET 2 K 4 THR D 214 ARG D 219 -1 O ARG D 219 N GLU D 222 SHEET 3 K 4 TYR D 257 GLN D 262 -1 N THR D 258 O GLN D 218 SHEET 4 K 4 LEU D 270 ARG D 273 -1 N LEU D 270 O VAL D 261 SHEET 1 L 4 LYS E 6 SER E 11 0 SHEET 2 L 4 ASN E 21 PHE E 30 -1 N ASN E 24 O TYR E 10 SHEET 3 L 4 PHE E 62 PHE E 70 -1 N PHE E 62 O PHE E 30 SHEET 4 L 4 GLU E 50 HIS E 51 -1 O GLU E 50 N TYR E 67 SHEET 1 M 4 LYS E 6 SER E 11 0 SHEET 2 M 4 ASN E 21 PHE E 30 -1 N ASN E 24 O TYR E 10 SHEET 3 M 4 PHE E 62 PHE E 70 -1 N PHE E 62 O PHE E 30 SHEET 4 M 4 SER E 55 PHE E 56 -1 O SER E 55 N TYR E 63 SHEET 1 N 4 GLU E 44 ARG E 45 0 SHEET 2 N 4 GLU E 36 LYS E 41 -1 N LYS E 41 O GLU E 44 SHEET 3 N 4 TYR E 78 ASN E 83 -1 O ALA E 79 N LEU E 40 SHEET 4 N 4 LYS E 91 LYS E 94 -1 O LYS E 91 N VAL E 82 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.03 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.02 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.35 SSBOND 4 CYS D 101 CYS D 164 1555 1555 2.03 SSBOND 5 CYS D 203 CYS D 259 1555 1555 2.03 SSBOND 6 CYS E 25 CYS E 80 1555 1555 2.37 CISPEP 1 TYR A 209 PRO A 210 0 0.12 CISPEP 2 HIS B 31 PRO B 32 0 -0.05 CISPEP 3 TYR D 209 PRO D 210 0 -0.15 CISPEP 4 HIS E 31 PRO E 32 0 0.06 CRYST1 49.950 62.930 74.650 82.07 76.50 78.04 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020020 -0.004241 -0.004427 0.00000 SCALE2 0.000000 0.016243 -0.001537 0.00000 SCALE3 0.000000 0.000000 0.013838 0.00000